SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000939767-18-000110
Filing Date
2018-05-24
Accepted
2018-05-24 20:30:34
Documents
2
Period of Report
2018-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_152720822079492.html 4  
1 FORM 4 wf-form4_152720822079492.xml 4 4146
2 POA_DEC 2017_SMITH ex-24.htm EX-24 3674
  Complete submission text file 0000939767-18-000110.txt   9398
Mailing Address 210 E. GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 210 E. GRAND AVE SOUTH SAN FRANCISCO CA 94080 6508377000
EXELIXIS, INC. (Issuer) CIK: 0000939767 (see all company filings)

IRS No.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0102
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services

Mailing Address C/O RAPTOR PHARMACEUTICAL CORP 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949
Business Address
Smith Julie (Reporting) CIK: 0001557928 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30235 | Film No.: 18859454